BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1921807)

  • 21. Hazards of prolonged low-dose methotrexate therapy.
    Bender AS
    Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
    [No Abstract]   [Full Text] [Related]  

  • 22. Pulmonary and hepatic complications of methotrexate therapy of psoriasis.
    Filip DJ; Logue GL; Harle TS; Farrar WH
    JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
    Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
    Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring methotrexate hepatotoxicity in psoriasis.
    Bishnoi P; Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2011; 77(5):545-8. PubMed ID: 21860151
    [No Abstract]   [Full Text] [Related]  

  • 25. Liver disease, erroneously attributed to methotrexate, in a patient with rheumatoid arthritis.
    Bills LJ; Seibert D; Brick JE
    J Rheumatol; 1992 Dec; 19(12):1963-5. PubMed ID: 1294748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal.
    Mayall B; Poggi G; Parkin JD
    Med J Aust; 1991 Oct; 155(7):480-4. PubMed ID: 1921820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
    Zachariae H; Bjerring P
    Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate.
    Christophidis N
    Clin Rheum Dis; 1984 Aug; 10(2):401-15. PubMed ID: 6334586
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis.
    Schwartz GF; Anderson ST
    J Rheumatol; 1990 Jul; 17(7):980. PubMed ID: 2213769
    [No Abstract]   [Full Text] [Related]  

  • 32. Noninvasive monitoring for methotrexate hepatotoxicity.
    MacDonald A; Burden AD
    Br J Dermatol; 2005 Mar; 152(3):405-8. PubMed ID: 15787807
    [No Abstract]   [Full Text] [Related]  

  • 33. Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
    Hall PD; Ahern MJ; Jarvis LR; Stoll P; Jenner MA; Harley H
    Ann Rheum Dis; 1991 Jul; 50(7):471-6. PubMed ID: 1877853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experience with methotrexate in the management of psoriasis].
    Mazzi R
    Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
    [No Abstract]   [Full Text] [Related]  

  • 35. Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis.
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Gaismayer K; Eberl R
    Int J Clin Pharmacol Res; 1989; 9(3):209-15. PubMed ID: 2545638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Methotrexate in the treatment of psoriasis].
    Grupper C; Bourgeois-Spinasse J
    Presse Med (1893); 1970 Sep; 78(37):1631-4. PubMed ID: 5455160
    [No Abstract]   [Full Text] [Related]  

  • 37. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
    Nyfors A
    Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamics of some indices of interstitial metabolism in patients with psoriasis during treatment with methotrexate].
    Smelov NS; Lashmanova AP; Nikitina LV; Fedorovskaia RF; Makashev TK
    Vestn Dermatol Venerol; 1975 Nov; (11):8-13. PubMed ID: 1220384
    [No Abstract]   [Full Text] [Related]  

  • 39. The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.
    Urowitz MB; Lee P
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):193-206. PubMed ID: 2032296
    [No Abstract]   [Full Text] [Related]  

  • 40. Cryptococcosis associated with low-dose methotrexate for arthritis.
    Altz-Smith M; Kendall LG; Stamm AM
    Am J Med; 1987 Jul; 83(1):179-81. PubMed ID: 3605168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.